#VisualAbstract: Chemoradiotherapy plus surgery improves 10-year overall survival compared to surgery alone in esophageal cancer

byTeddy Guo

July 8, 2021

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract Ibrutinib may be beneficial in heavily pretreated patients with classic and variant hairy cell leukemia

RelatedReports

No difference in PET-CT surveillance versus planned neck dissection in advanced head and neck cancer

Chronic Disease

Hyperfractionated radiotherapy reduces complication rates compared to standard fractionation for locally advanced nasopharyngeal carcinoma

March 29, 2023

Nivolumab may be effective in platinum-resistant ovarian cancer

Gastroenterology

Addition of PD-L1 inhibitor may improve outcomes in neoadjuvant therapy for esophageal cancer

March 15, 2023

StudyGraphics

#StudyGraphics: Gastric bypass surgery may reduce the risk of esophagogatric cancer in obese patients

March 14, 2023

StudyGraphics

#StudyGraphics: Concomitant chemoradiotherapy improves survival in elderly adults with locally advanced head and neck squamous cell carcinoma

March 9, 2023

Celiac disease more prevalent in children with irritable bowel syndrome

Transglutaminase 2 inhibition attenuates mucosal injury in patients with celiac disease

Incidental findings common with breast imaging, often benign

Tamoxifen decreases recurrence rates at 25 years in lymph node-negative estrogen-receptor-positive and Erb-B2 Receptor Tyrosine Kinase 2-negative breast cancer

Active smoking cessation intervention may provide tangible results [Project CLIQ]

Systematic analysis of tobacco smoking prevalence in 204 countries from 1990 to 2019

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

#VisualAbstract: Chemoradiotherapy plus surgery improves 10-year overall survival compared to surgery alone in esophageal cancer

Hyperfractionated radiotherapy reduces complication rates compared to standard fractionation for locally advanced nasopharyngeal carcinoma

Addition of PD-L1 inhibitor may improve outcomes in neoadjuvant therapy for esophageal cancer

#StudyGraphics: Gastric bypass surgery may reduce the risk of esophagogatric cancer in obese patients

#VisualAbstract Ibrutinib may be beneficial in heavily pretreated patients with classic and variant hairy cell leukemia

Transglutaminase 2 inhibition attenuates mucosal injury in patients with celiac disease

RelatedReports

Hyperfractionated radiotherapy reduces complication rates compared to standard fractionation for locally advanced nasopharyngeal carcinoma

Addition of PD-L1 inhibitor may improve outcomes in neoadjuvant therapy for esophageal cancer

#StudyGraphics: Gastric bypass surgery may reduce the risk of esophagogatric cancer in obese patients

#StudyGraphics: Concomitant chemoradiotherapy improves survival in elderly adults with locally advanced head and neck squamous cell carcinoma

Transglutaminase 2 inhibition attenuates mucosal injury in patients with celiac disease

Tamoxifen decreases recurrence rates at 25 years in lymph node-negative estrogen-receptor-positive and Erb-B2 Receptor Tyrosine Kinase 2-negative breast cancer

Systematic analysis of tobacco smoking prevalence in 204 countries from 1990 to 2019

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written
medical news?

#VisualAbstract: Chemoradiotherapy plus surgery improves 10-year overall survival compared to surgery alone in esophageal cancer

RELATED REPORTS

#VisualAbstract Ibrutinib may be beneficial in heavily pretreated patients with classic and variant hairy cell leukemia

Transglutaminase 2 inhibition attenuates mucosal injury in patients with celiac disease

RelatedReports

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written medical news?

Want more physician-written
medical news?